Znanstveni rad - Izvorni znanstveni rad
Plasminogen Activator Inhibitor-1 Concentrations and Bone Mineral Density in Postmenopausal Women with Type 2 Diabetes Mellitus

Canecki-Varžić, Silvija; Prpić-Križevac, Ivana; Bilić-Ćurčić, Ines (2016)
Citirajte ovaj rad

Canecki Varžić, S., Prpić Križevac, I. i Bilić Ćurčić, I. (2016). Plasminogen Activator Inhibitor-1 Concentrations and Bone Mineral Density in Postmenopausal Women with Type 2 Diabetes Mellitus. BMC Endocrine Disorders, 14., 1-7. doi: 10.1186/s12902-016-0094-x

Canecki Varžić, Silvija, et al. "Plasminogen Activator Inhibitor-1 Concentrations and Bone Mineral Density in Postmenopausal Women with Type 2 Diabetes Mellitus." BMC Endocrine Disorders, vol. 14, 2016, str. 1-7. https://doi.org/10.1186/s12902-016-0094-x

Canecki Varžić, Silvija, Ivana Prpić Križevac i Ines Bilić Ćurčić. "Plasminogen Activator Inhibitor-1 Concentrations and Bone Mineral Density in Postmenopausal Women with Type 2 Diabetes Mellitus." BMC Endocrine Disorders 14 (2016): 1-7. https://doi.org/10.1186/s12902-016-0094-x

Canecki Varžić, S., Prpić Križevac, I. i Bilić Ćurčić, I. (2016) 'Plasminogen Activator Inhibitor-1 Concentrations and Bone Mineral Density in Postmenopausal Women with Type 2 Diabetes Mellitus', BMC Endocrine Disorders, 14, str. 1-7. doi: 10.1186/s12902-016-0094-x

Canecki Varžić S, Prpić Križevac I, Bilić Ćurčić I. Plasminogen Activator Inhibitor-1 Concentrations and Bone Mineral Density in Postmenopausal Women with Type 2 Diabetes Mellitus. BMC Endocrine Disorders [Internet]. 2016. [pristupljeno 19.11.2019.];14:1-7. doi: 10.1186/s12902-016-0094-x

S. Canecki Varžić, I. Prpić Križevac i I. Bilić Ćurčić, "Plasminogen Activator Inhibitor-1 Concentrations and Bone Mineral Density in Postmenopausal Women with Type 2 Diabetes Mellitus", BMC Endocrine Disorders, vol. 14, str. 1-7, 2016. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:239:903108. [Citirano: 19.11.2019.]